These results demonstrate that the protective effect of CAV1 on APAP-induced liver injury in NAFLD may be associated with activation of the AMPK/Nrf2-dependent pathway. The gene discussed is CAV1; the disease is metabolic dysfunction-associated steatotic liver disease.